A Study of GNC-038, a Tetra-specific Antibody, in Patients With Central Nervous System Lymphoma (PCNSL) and Relapsed or Refractory Secondary Central Nervous System Lymphoma (SCNSL)
Conditions: Primary Central Nervous System Lymphoma; Secondary Central Nervous System Lymphoma Intervention: Drug: GNC-038 Sponsors: Sichuan Baili Pharmaceutical Co., Ltd.; SystImmune Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials